Singapore trial under way on use of Lianhua Qingwen in treating mild Covid-19

The study, approved on Jan 18, was initiated by the Singapore Chung Hwa Medical Institution, said the Health Sciences Authority in response to CNA's queries on Tuesday .

"A secondary purpose is to assess how it may have a further effect on the time taken to obtain a negative ART test result." A total of 300 people, aged between 21 and 79, are expected to be involved in the trial, according to the clinicaltrials.gov website — an international database of clinical studies maintained by the United States National Library of Medicine.

It added that investigators hypothesise that TCM intervention could reduce the time of eight major Covid-19 symptoms, including fever, sore throat and body aches, as well as reduce the time to a negative ART result for mild coronavirus cases by up to 1.5 times.Lianhua Qingwen is available at some retail shops in Singapore.on social media and in chat groups that Lianhua Qingwen could be used to prevent or treat Covid-19.

I wish there were betting market on this, there's such a low probability of this actually working

Wonder what happened

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Singapore trial under way on use of Lianhua Qingwen in treating mild COVID-19SINGAPORE: A clinical trial has been approved in Singapore to study the use of traditional Chinese medicine Lianhua Qingwen in treating adults with mild COVID-19. The study, approved on Jan 18, was initiated by the Singapore Chung Hwa Medical Institution, said the Health Sciences Authority ( « Singapore trial » means Singapore will study other countries’ studies. Cute. Allah SWT mengajar umat Islam mengenai Pakistan tetapi mereka tidak memahami begitu juga dgn rakyat Pakistan. Muhammad Qasim melihat bahawa Pakistan mempunyai kepentingan utama dalam Islam dan masa depan umat Islam. Ketahui lebih lanjut tentang hal ini di
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »